Global /Canada /Healthcare /Drug Manufacturers - Specialty & Generic /XTRX
chevron_leftBack
Adastra Holdings Ltd. logo

Adastra Holdings Ltd.

XTRX
CSE: XTRX Delayed
0.2000CAD 0%
0.1439 USD
As of 6 June 2026, Adastra Holdings Ltd. has a market cap of $802.48K USD, ranking #48731 globally and #2744 in Canada. It ranks #4326 in the Healthcare sector, and #355 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
48731
Country Rank
2744
Sector Rank
4326
Industry Rank
355
Key Stats
Market Cap
$802.48KUSD
1.12M CAD
Enterprise Value
$2.81MUSD
3.9M CAD
Revenue (TTM)
$12.09MUSD
16.86M CAD
EBITDA (TTM)
-$1.47MUSD
-2.04M CAD
Net Income (TTM)
-$10.39MUSD
-14.49M CAD
EBITDA Margin
-12%
Profit Margin
-86%
PS Ratio
0.1
PB Ratio
-1.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lachlan McLeod open_in_new
Website
adastraholdings.ca open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% - 0% -7% -11% -40%

News

Loading...

Markets

Exchange Ticker Price
Canadian Securities Exchange
MIC: XCNQ
PRIMARY
XTRX
Adastra Holdings Ltd Ordinary Shares
ISIN: CA00654D2095
Shares Out.:
5.597M1 Shares Float: 5.526M2
TV:
SA:
YF:
GF:
BA:
MS:
0.2000 CAD
Cboe Canada
MIC: NEOE
XTRX
Adastra Holdings Ltd Ordinary Shares
ISIN: CA00654D2095
TV:
SA:
YF:
GF:
BA:
MS:
0.2100 CAD
OTC Markets
MIC: OTCM
XTXXF
Adastra Holdings Ltd Ordinary Shares
ISIN: CA00654D2095
TV:
SA:
YF:
GF:
BA:
MS:
0.0127 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Adastra Holdings Ltd.

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada. The company offers vape pens, wax, resin, infused pre-rolls, diamonds, and shatters under the Endgame brand. It also provides consulting and white label manufacturing. The company was formerly knowns as Phyto Extractions Inc. and changed its name to Adastra Holdings Ltd. in September 2021. Adastra Holdings Ltd. is headquartered in Langley, Canada.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Canada)
Name
Market Cap diff.
PE
$2.08B
2.9B CAD
259K%
13.5
$999.68M
1.39B CAD
124K%
23.0
CRON
$983.67M
1.37B CAD
122K%
-
$332.74M
464.15M CAD
41K%
12.7
$126.05M
175.83M CAD
16K%
14.9
$83.94M
117.1M CAD
10K%
1.1
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
5M%
24.2
$29.56B
4M%
-
$15.86B
107.34B CNY
2M%
16.0
CIPLA
$11.12B
1.06T INR
1M%
23.4
LUPIN
$11.0B
1.05T INR
1M%
22.7
$9.1B
61.6B CNY
1M%
80.6
chevron_leftBack